United States Agency for International Development, Academic Model Providing Access To Healthcare Partnership, Eldoret, Kenya.
Bull World Health Organ. 2010 Sep 1;88(9):681-8. doi: 10.2471/BLT.09.064329. Epub 2010 Apr 16.
To determine the incidence of loss to follow-up in a treatment programme for people living with human immunodeficiency virus (HIV) infection in Kenya and to investigate how loss to follow-up is affected by gender.
Between November 2001 and November 2007, 50 275 HIV-positive individuals aged ≥ 14 years (69% female; median age: 36.2 years) were enrolled in the study. An individual was lost to follow-up when absent from the HIV treatment clinic for > 3 months if on combination antiretroviral therapy (cART) or for > 6 months if not. The incidence of loss to follow-up was calculated using Kaplan-Meier methods and factors associated with loss to follow-up were identified by logistic and Cox multivariate regression analysis.
Overall, 8% of individuals attended no follow-up visits, and 54% of them were lost to follow-up. The overall incidence of loss to follow-up was 25.1 per 100 person-years. Among the 92% who attended at least one follow-up visit, the incidence of loss to follow-up before and after starting cART was 27.2 and 14.0 per 100 person-years, respectively. Baseline factors associated with loss to follow-up included younger age, a long travel time to the clinic, patient disclosure of positive HIV status, high CD4+ lymphocyte count, advanced-stage HIV disease, and rural clinic location. Men were at an increased risk overall and before and after starting cART.
The risk of being lost to follow-up was high, particularly before starting cART. Men were more likely to become lost to follow-up, even after adjusting for baseline sociodemographic and clinical characteristics. Interventions designed for men and women separately could improve retention.
确定肯尼亚艾滋病毒感染者治疗方案中失访的发生率,并探讨失访如何受性别影响。
2001 年 11 月至 2007 年 11 月期间,共有 50275 名年龄≥14 岁(69%为女性;中位年龄 36.2 岁)的艾滋病毒阳性个体入组研究。如果正在接受联合抗逆转录病毒疗法(cART),个体在 HIV 治疗诊所中未出现超过 3 个月则为失访;如果未接受 cART,则未出现超过 6 个月则为失访。使用 Kaplan-Meier 方法计算失访的发生率,并通过逻辑和 Cox 多变量回归分析确定与失访相关的因素。
总体而言,有 8%的个体未参加任何随访就诊,其中 54%的个体失访。总体失访发生率为 25.1/100 人年。在至少参加一次随访就诊的 92%个体中,在开始 cART 之前和之后失访的发生率分别为 27.2 和 14.0/100 人年。与失访相关的基线因素包括年龄较小、到诊所的交通时间较长、患者透露艾滋病毒阳性状态、较高的 CD4+淋巴细胞计数、晚期 HIV 疾病和农村诊所位置。总体而言,男性失访风险增加,且在开始 cART 之前和之后均增加。
失访风险很高,尤其是在开始 cART 之前。即使在调整了基线社会人口学和临床特征后,男性仍更有可能失访。针对男性和女性分别设计的干预措施可能会提高保留率。